# Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

> **NCT00433225** · PHASE4 · COMPLETED · sponsor: **Innovative Medical**

## Conditions studied

- Macula Thickening

## Interventions

- **DRUG:** Prednisolone Acetate
- **DRUG:** Ketorolac 0.4%
- **DRUG:** Gatifloxacin 0.3%

## Key facts

- **NCT ID:** NCT00433225
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433225, "Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00433225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*